Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

Cesare Hassan, A Zullo, E Ierardi, V. De Francesco

Risultato della ricerca: Contributo in rivistaArticolo in rivista

27 Citazioni (Scopus)

Abstract

Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.
Lingua originaleEnglish
pagine (da-a)11-17
Numero di pagine7
RivistaSaudi Journal of Gastroenterology
Volume18
DOI
Stato di pubblicazionePubblicato - 2012
Pubblicato esternamente

Keywords

  • Anti-Infective Agents, Local
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Furazolidone
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans

Fingerprint

Entra nei temi di ricerca di 'Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis'. Insieme formano una fingerprint unica.

Cita questo